XW013U6Introduction of COVID-19 Vaccine into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6

XW013U6 is the ICD-10-PCS code for a introduction procedure on the subcutaneous tissue using a percutaneous approach with COVID-19 vaccine (qualifier: new technology group 6). In ICD-10-PCS, introduction means putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

For a different body part, codes include XW023U6 (muscle).

With a different device, use XW013G6 (vancomycin hydrochloride and tobramycin sulfate anti-infective, temporary irrigation spacer system), XW013H6 (paclitaxel-coated balloon technology, one balloon), XW013K6 (paclitaxel-coated balloon technology, three balloons), XW013S6 (iobenguane I-131 antineoplastic) and XW013T6 (melphalan hydrochloride antineoplastic).

It doesn't appear in the MS-DRG procedure index, so on its own it doesn't change the DRG assignment.

It was added in FY2021, effective October 1, 2020.